MedPath

ADENOSINE

ADENOSINE INJECTION, USP 6mg/2mL (3mg/mL) 2mL VIAL

Approved
Approval ID

fa6eb0f8-7c41-2e17-e053-6294a90ac8ca

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Apr 28, 2023

Manufacturers
FDA

HF Acquisition Co LLC, DBA HealthFirst

DUNS: 045657305

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

ADENOSINE

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code51662-1631
Application NumberANDA078686
Product Classification
M
Marketing Category
C73584
G
Generic Name
ADENOSINE
Product Specifications
Route of AdministrationINTRAVENOUS
Effective DateApril 28, 2023
FDA Product Classification

INGREDIENTS (3)

SODIUM CHLORIDEInactive
Code: 451W47IQ8X
Classification: IACT
WATERInactive
Code: 059QF0KO0R
Classification: IACT
ADENOSINEActive
Quantity: 3 mg in 1 mL
Code: K72T3FS567
Classification: ACTIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.